ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia

BACKGROUND: In acute myeloid leukemia (AML), internal tandem duplication mutations in the FLT3 tyrosine kinase receptor (FLT3-ITD) are associated with a dismal outcome. Although uncoordinated 51-like kinase 1 (ULK1), which plays a central role in the autophagy pathway, has emerged as a novel therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Doh Yu, Eom, Ju-In, Jang, Ji Eun, Jeung, Hoi-Kyung, Chung, Haerim, Kim, Jin Seok, Cheong, June-Won, Min, Yoo Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212592/
https://www.ncbi.nlm.nih.gov/pubmed/32393312
http://dx.doi.org/10.1186/s13046-020-01580-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212592/
https://www.ncbi.nlm.nih.gov/pubmed/32393312
http://dx.doi.org/10.1186/s13046-020-01580-4

Ejemplares similares